Abeona Therapeutics Inc.ABEONASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank71
3Y CAGR+40.9%
5Y CAGR+26.9%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+40.9%/yr
vs -37.6%/yr prior
5Y CAGR
+26.9%/yr
Recent acceleration
Acceleration
+78.6pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
202547.95-
20240.00-100.0%
202330.60+78.7%
202217.13+53.5%
202111.16-23.3%
202014.55-
20190.00-100.0%
2018113.18-85.6%
2017788.24+322.8%
2016186.44-